Chemomab Therapeutics Ltd. (CMMB)

1.57 -0.07 (-4.27%) USD  |  NASDAQ  |  Feb 20, 16:00
1.57 0.00 (0.00%) After-Hours: 20:00
More

Chemomab Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CMMB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Compugen Ltd. Upgrade
Pluri, Inc. Upgrade
BioLineRx Ltd. Upgrade
XTL Biopharmaceuticals Ltd. Upgrade
Can-Fite BioPharma Ltd. Upgrade